VIP (vasoactive intestinal peptide) is a 28-amino-acid neuropeptide of the secretin/glucagon peptide superfamily. It is a well-characterized reference compound in neuroimmunology and receptor-signaling research.
VIP acts on VPAC receptors and is studied across preclinical contexts ranging from vasodilation and smooth-muscle signaling to circadian and immune research.
In laboratory models, VIP has been investigated for immunomodulatory and anti-inflammatory signaling, circadian-rhythm regulation, and neuroprotection research. These observations are limited to laboratory and preclinical research settings and are not statements about outcomes in humans.
Supplied as a lyophilized powder. Store lyophilized material at -20°C. Reconstitution with bacteriostatic or sterile water is common for laboratory handling; keep any reconstituted solution refrigerated and use it within the timeframe appropriate to the researcher’s protocol.
Purity is determined by HPLC and identity is confirmed by mass spectrometry. Each batch ships with a batch-specific certificate of analysis from an independent third-party laboratory; refer to the COA for lot-specific measured values. Endotoxin and sterility testing are not performed unless explicitly stated.
VIP is a 28-amino-acid neuropeptide used as a reference compound in neuroimmunology and receptor-signaling laboratory research.
Store the lyophilized powder at -20°C. Handle and store any reconstituted solution per your laboratory protocol.
Purity by HPLC and identity by mass spectrometry, batch-specific, from an independent third-party lab. Refer to the COA for the measured purity. Endotoxin and sterility are not tested unless stated.
No. It is sold strictly for in-vitro laboratory research and is not for human or veterinary use.